DataMeds AI, Inc.
MEDS· Nasdaq
Released Aug 17, 2026, after the close
10-Q filed Aug 17, 2026, 48 days after period end · 0001493152-26-038581
| Metric | Q2 2026 | Q2 2025 | Q2 2024 |
|---|---|---|---|
| Revenue | $1.78M | $7.79M | $44.54K |
| Net Income | -$18.36M | -$6.67M | -$574.33K |
| EPS Diluted | -$7.13 | -$5.40 | -$0.01 |
DataMeds AI, Inc. · CIK 2030763 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.